Breaking Down Humana: 11 Analysts Share Their Views
Portfolio Pulse from Benzinga Insights
Humana (NYSE:HUM) has been analyzed by 11 analysts, showing a range of ratings from bullish to bearish. The average 12-month price target is $384.82, up 5.14% from the previous target. Analysts have adjusted their ratings and price targets, reflecting their views on Humana's market position and financial performance.
September 05, 2024 | 8:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Humana has received a range of analyst ratings, with an average price target increase to $384.82. Analysts have adjusted their ratings, reflecting a mix of bullish and neutral sentiments. Humana's financials show strong ROE and ROA but challenges in net margin and debt management.
The increase in the average price target and the adjustments in analyst ratings suggest a positive short-term outlook for Humana. The company's strong ROE and ROA indicate effective financial management, which is likely to support stock performance. However, challenges in net margin and high debt-to-equity ratio may temper expectations.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100